Apply for a Research Grant
Letter of Intent due: March 14, 2023 (See LOI guidelines within the RFP.)
Full Application due: April 25, 2023
Learn more about the DTRF Dr. Dina Lev Early Career Investigator Grant, named in honor of Dina Chelouche Lev, M.D., an early leader in desmoid tumor research.
Forms for Grant Applications:
Forms for Reports:
Desmoid Cell Line at ATCC
The FIRST publicly available desmoid tumor immortal cell line, HCM-BROD-0762-C49, is now available for purchase at ATCC, a public biorepository based in Manassas, VA. This cell line is positive for the CTNNB1 T41A mutation. It was created by the Cancer Cell Line Factory at the Broad Institute as part of the Human Cancer Model Initiative (HCMI). This tumor-derived model can be used in basic research as well as pharmacological screening applications. Detailed information about this model can be found on the ATCC website and on the HCMI website. Discounted pricing is available to academic researchers.
To sign up for our physician newsletter, subscribe here.
Feel free to contact us with any questions. Thank you for your interest in desmoid tumor research!